D. Xie

发表

: Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and

Bin Liu, Li Dong Wang, F. Zhou, 2010 .

Joint analysis of three genome- wide association studies of esophageal squamous cell carcinoma in Chinese populations

Hongbing Shen, N. Hu, S. Chanock, 2014 .

Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies.

N. Hu, S. Chanock, K. Jacobs, 2012, Human molecular genetics.

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1

Bin Liu, Li Dong Wang, F. Zhou, 2010, Nature Genetics.

Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors

Carl W. Miller, D. Xie, K. Black, 2002, Oncogene.

MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.

D. Xie, Shuqun Cheng, Nan Li, 2012, Journal of hepatology.

PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway

D. Xie, Kang Wang, Shuqun Cheng, 2018, Cellular Physiology and Biochemistry.

Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and β-Catenin-TCF/Lef Signaling Pathways

Dong Xie, Carl W. Miller, Dorina Gui, 2004, Cancer Research.

Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas

Dong Xie, Robert Elashoff, R. Elashoff, 2004, Clinical Cancer Research.

Sorafenib enriches epithelial cell adhesion molecule–positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2‐AKT cascade

Lin Qiu, Yang Zhang, D. Xie, 2015, Hepatology.

Down‐regulated desmocollin‐2 promotes cell aggressiveness through redistributing adherens junctions and activating beta‐catenin signalling in oesophageal squamous cell carcinoma

E. Li, Li-Yan Xu, Zhiyong Wu, 2013, The Journal of pathology.

Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung Cancer

Yan Wang, Song Zhao, Dong Xie, 2007, PloS one.

Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.

R. Elashoff, R. Elashoff, D. Xie, 2001, Cancer research.

Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through β-Catenin-T-cell Factor/Lef Signaling*

D. Xie, H. Koeffler, Baojie Li, 2007, Journal of Biological Chemistry.

Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer*

Carl W. Miller, D. Xie, H. Koeffler, 2001, The Journal of Biological Chemistry.

Overexpression of degenerative spermatocyte homolog 1 up‐regulates the expression of cyclin D1 and enhances metastatic efficiency in esophageal carcinoma Eca109 cells

D. Xie, X. Ji, Xiao-lei Ye, 2009, Molecular carcinogenesis.

SOX7 is down-regulated in lung cancer

S. Mori, D. Xie, H. P. Koeffler, 2013, Journal of experimental & clinical cancer research : CR.

Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF‐κB signaling pathway

D. Xie, Xiao-Fan Wang, Yun-fei Yuan, 2010, Hepatology.

RACK 1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway

D. Xie, X. Ji, Jiang-Sha Zhao, 2012 .

An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.

D. Xie, W. Lau, W. Cong, 2019, The oncologist.

All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.

Yang Zhang, D. Xie, Hong-Yang Wang, 2013, Journal of hepatology.

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44

Li-Yan Xu, D. Xie, Xiao-Fan Wang, 2011, PloS one.

RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.

Yong Liu, E. Li, Li-Yan Xu, 2012, Gastroenterology.

Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.

D. Xie, Shuqun Cheng, Nan Li, 2013, Asian Pacific journal of cancer prevention : APJCP.

IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells

D. Xie, Lei Cui, D. Jin, 2012, Tumor Biology.

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis

D. Xie, Dianzhen Yu, Hui-Jun Cao, 2021, Toxins.

Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.

Zhong-ying Shen, E. Li, Li-Yan Xu, 2010, The American journal of pathology.

Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma

Lin Qiu, D. Xie, Hui-Jun Cao, 2022, Cellular and Molecular Gastroenterology and Hepatology.

Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling.

Hao Jiang, D. Xie, Xiang Gao, 2014, Immunity.

PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

Lin Qiu, D. Xie, Hui-Jun Cao, 2022, Oncogene.

AIM-2: A Novel Tumor Antigen is Expressed and Presented by Human Glioma Cells

D. Xie, K. Black, Gentao Liu, 2004, Journal of immunotherapy.

DLK1: increased expression in gliomas and associated with oncogenic activities

D. Xie, K. Black, C. Miller, 2006, Oncogene.

Autophagy Induced by NGAL Protein in Esophageal Carcinoma Cells*: Autophagy Induced by NGAL Protein in Esophageal Carcinoma Cells*

Zhong-ying Shen, D. Xie, You-hong Cui, 2009 .

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma

D. Xie, Shuqun Cheng, Xiuping Zhang, 2018, Cancer medicine.

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme

J. Vadgama, D. Xie, K. Black, 2010, International journal of cancer.

Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells

D. Xie, X. Tong, Y. Wang, 2008, British Journal of Cancer.

hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling.

Hao Jiang, D. Xie, Xiao-yan Zhou, 2018, Cancer research.

ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2

Lin Qiu, D. Xie, Hui-Jun Cao, 2022, Cell Death & Differentiation.

RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway*

D. Xie, X. Ji, Jiang-Sha Zhao, 2012, The Journal of Biological Chemistry.

PPDPF Promotes the Development of Mutant KRAS‐Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1

D. Xie, Xiao-Fan Wang, F. Yin, 2022, Advanced science.

From Pixel to Whole Slide: Automatic Detection of Microvascular Invasion in Hepatocellular Carcinoma on Histopathological Image via Cascaded Networks

Junzhou Huang, Dong Xie, Jiangpeng Yan, 2021, International Conference on Medical Image Computing and Computer-Assisted Intervention.

Long-Noncoding RNA ANCR Activates the Hedgehog Signaling Pathway to Promote Basal Cell Carcinoma Progression by Binding to PTCH

D. Xie, Jianqiao Wang, Hongxuan Wu, 2022, Clinical, cosmetic and investigational dermatology.

CCID_A_345371 955..965

D. Xie, Jianqiao Wang, Hongxuan Wu, 2022 .

RACK1 modulates NF-κB activation by interfering with the interaction between TRAF2 and the IKK complex

D. Xie, Yingqi Zhu, Jingjing Li, 2013, Cell Research.

Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis

D. Xie, Hui-Jun Cao, Kang Wang, 2021, Oncogene.

Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers.

D. Xie, Ping Chen, X. Tong, 2007, Cancer research.

A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis

Li Ma, D. Xie, Jenny C. Chang, 2021, Nature Communications.

Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis

Lin Qiu, D. Xie, Hui-Jun Cao, 2020, Proceedings of the National Academy of Sciences.

TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

D. Xie, Xiao-Fan Wang, Pengyuan Yang, 2012, Cancer cell.

CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer

D. Xie, Lei Cui, Xin Fan, 2012, Tumor Biology.

Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells

Dong Xie, Carl W. Miller, Carl Miller, 2005, Clinical Cancer Research.

SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway

D. Xie, D. Chia, L. Goodglick, 2015, The Journal of pathology.

Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β‐catenin/TCF/LEF signalling

D. Xie, F. Yin, Hui-Jun Cao, 2019, Cell proliferation.

The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b

D. Xie, Wu Zhou, Xiao-lei Ye, 2017, Science Signaling.

The lncRNA H 19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200 b / c and let-7 b

D. Xie, Wu Zhou, Xiao-lei Ye, 2017 .

EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex

D. Xie, X. Ji, Jiang-Sha Zhao, 2012, Nature Communications.

EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration.

D. Xie, X. Ji, Jiang-Sha Zhao, 2011, Cancer research.

Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers.

D. Xie, Dongping Liu, X. Tong, 2008, Cancer research.

Regulatory Factor 2 in Esophageal Cancers Pathway by IFN γ Negative Feedback Regulation of IFN-Updated

D. Xie, Dongping Liu, X. Tong, 2008 .

DNA repair gene O6‐methylguanine‐DNA methyltransferase: Promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors

D. Xie, K. Black, W. Hofmann, 2003, Molecular carcinogenesis.

Cleavage of focal adhesion kinase (FAK) is essential in adipocyte differentiation.

D. Xie, Jingjing Li, 2007, Biochemical and biophysical research communications.

A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

D. Xie, Y. Yen, L. Xu, 2014, Clinical Cancer Research.

MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma

D. Xie, W. Zhou, M. Ding, 2014, Oncogenesis.

Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells

D. Xie, Z. Wang, Yi Pan, 2013, PloS one.

EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer*

D. Xie, F. Yin, Jingjing Li, 2016, The Journal of Biological Chemistry.

A Combined Proteomics and Metabolomics Profiling of Gastric Cardia Cancer Reveals Characteristic Dysregulations in Glucose Metabolism*

Li-Yan Xu, D. Xie, R. Qi, 2010, Molecular & Cellular Proteomics.

Ephrin-A 1 is a negative regulator in glioma through down-reguation of EphA 2 and FAK

D. Xie, Yan Wang, H. Koeffler, 2022 .

SOX7 is down-regulated in lung cancer

S. Mori, D. Xie, P. Tan, 2013, Journal of experimental & clinical cancer research : CR.

Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β-catenin–c-myc–p53 pathway

Carl W. Miller, D. Xie, A. Mori, 2004, Oncogene.

Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model

D. Xie, Xiao-Fan Wang, Hong-Yang Wang, 2011, Hepatology.

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

D. Amadori, D. Xie, Xiao-Fan Wang, 2013, Nature Cell Biology.

Proteomics in gastric cancer research: Benefits and challenges

D. Xie, R. Qi, Jingjing Li, 2009, Proteomics. Clinical applications.

Hepatic Deletion of Smad7 in Mouse Leads to Spontaneous Liver Dysfunction and Aggravates Alcoholic Liver Injury

D. Xie, Rui Zhang, Yi Pan, 2011, PloS one.

Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis

D. Xie, Xiao-Fan Wang, Nan Li, 2018, British Journal of Cancer.

PRMT1 promotes pancreatic cancer growth and predicts poor prognosis

D. Xie, W. Lou, Y. Rong, 2019, Cellular Oncology.

INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.

D. Xie, Jingjing Li, Tianwei Chen, 2021, Experimental cell research.

Epithelial V‐like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB‐PI3K‐AKT pathway

D. Xie, Shuqun Cheng, Xingyuan Ma, 2020, Cancer science.

Iron overload in hereditary tyrosinemia type 1 induces liver injury through the Sp1/Tfr2/hepcidin axis.

D. Xie, Xiao-Fan Wang, Xin Wang, 2016, Journal of hepatology.

Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma

D. Xie, N. Li, J. Xue, 2010, British Journal of Cancer.

Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation

Zhong-ying Shen, E. Li, Li-Yan Xu, 2010, Cellular and Molecular Life Sciences.

Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma.

D. Xie, Shuqun Cheng, Yabo Jiang, 2020, Oncology letters.

CHML promotes liver cancer metastasis by facilitating Rab14 recycle

Lin Qiu, D. Xie, Xiao-Fan Wang, 2019, Nature Communications.

A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response

Qiang Yu, D. Xie, Xin Zhang, 2012, Nature Communications.

Cyclin G1–mediated epithelial‐mesenchymal transition via phosphoinositide 3‐kinase/Akt signaling facilitates liver cancer progression

T. Han, D. Xie, Hongyang Wang, 2012, Hepatology.

Cilia loss sensitizes cells to transformation by activating the mevalonate pathway

Hao Jiang, D. Xie, Xiao-Fan Wang, 2018, The Journal of experimental medicine.

Dual role for inositol‐requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet‐induced obesity in mice

D. Xie, Jing Fang, L. Rui, 2018, Hepatology.

Imprinting status of DLK1 gene in brain tumors and lymphomas.

Carl W. Miller, S. de Vos, D. Xie, 2004, International journal of oncology.

Identification of 5-Iodotubercidin as a Genotoxic Drug with Anti-Cancer Potential

D. Xie, Xin Zhang, Baojie Li, 2013, PloS one.

TMEFF1 and brain tumors

D. Xie, K. Black, H. Koeffler, 2003, Oncogene.

BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis

D. Xie, F. Yin, Kang Wang, 2019, Oncogene.

SETDB1 accelerates tumorigenesis by regulating WNT signaling pathway

D. Xie, D. Chia, L. Goodglick, 2015 .

Title SETDB 1 accelerates tumourigenesis by regulating the WNT signalling pathway

D. Xie, D. Chia, L. Goodglick, 2015 .

Expression levels of EPHB4, EFNB2 and caspase-8 are associated with clinicopathological features and progression of esophageal squamous cell cancer

D. Xie, Xingyuan Ma, Jingjing Li, 2019, Oncology letters.

TMEM229A suppresses non-small cell lung cancer progression via inactivating the ERK pathway

D. Xie, Xi-lin Zhang, Ying He, 2021, Oncology reports.

The roles and therapeutic potentials of Ephs and ephrins in lung cancer.

D. Xie, Jingjing Li, 2013, Experimental cell research.

Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells.

D. Xie, Lin Qiu, F. Yin, 2017, Biochemical and biophysical research communications.

Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis

D. Xie, Xi-lin Zhang, Tianwei Chen, 2022, Molecular oncology.

Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.

D. Xie, W. Lau, W. Cong, 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

PRMT1 promotes pancreatic cancer growth and predicts poor prognosis

D. Xie, W. Lou, Y. Rong, 2019, Cellular Oncology.

CHML promotes liver cancer metastasis by facilitating Rab14 recycle

D. Xie, Xiao-Fan Wang, Lin Qiu, 2019, Nature Communications.

Signaling Pathways-Catenin-TCF / Lef β Integrin-Linked Kinase-Mediated Akt and Cyr 61 Is Overexpressed in Gliomas and Involved in Updated

Carl W. Miller, D. Xie, K. Black, 2004 .

An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study

D. Xie, Li Xu, Minshan Chen, 2019, Hepatology.

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling

Lin Qiu, D. Xie, Xiao-Fan Wang, 2021, Nature Communications.

Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus

D. Xie, Shuqun Cheng, Nan Li, 2010, Journal of experimental & clinical cancer research : CR.

Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer

D. Xie, Xi-lin Zhang, Y. Bao, 2019, Oncology letters.

PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1.

D. Xie, Hui-Jun Cao, Kang Wang, 2023, Cell reports.

SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells

Hao Jiang, D. Xie, W. Lou, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

PES1 reduces CD8+ T cell infiltration and immunotherapy sensitivity via interrupting ILF3-IL15 complex in esophageal squamous cell carcinoma

Yang Yang, D. Xie, Ning Ma, 2023, Journal of Biomedical Science.

Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H

D. Xie, Xi-lin Zhang, Tianwei Chen, 2022, International journal of oncology.

Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.

D. Xie, Yan Wang, H. Koeffler, 2007, International journal of oncology.

Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China.

Jilin Li, Z. Fan, Xiaoshan Feng, 2005, World journal of gastroenterology.